DANIEL B SOLAND Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DANIEL B SOLAND.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DANIEL B SOLAND. DANIEL B SOLAND is a VP; President, Chiron Vaccines in CHIRON CORP ($CHIR) and a Chief Operating Officer in IDERA PHARMACEUTICALS, INC. ($IDRA) and a in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in ACADIA PHARMACEUTICALS INC ($ACAD) and a Director in KalVista Pharmaceuticals, Inc. ($KALV).
Address: 4560 HORTON STREET EMERYVILLE 94608 CA
Companies in which DANIEL B SOLAND is an Insider
ACADIA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL B SOLAND: Director
Holdings: 2,000 shares
Current Value: $76,380
Latest Transaction: Jun 24 2021
$ACAD Market Capitalization: $4.67B
$ACAD Previous Close: $38.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHIRON CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL B SOLAND: VP; President, Chiron Vaccines
Holdings: 0 shares
Latest Transaction: Apr 20 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDERA PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL B SOLAND: Chief Operating Officer
Holdings: 28,843 shares
Current Value: $44,995
Latest Transaction: Mar 05 2021
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KalVista Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL B SOLAND: Director
Holdings: 2,038 shares
Latest Transaction: Oct 02 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DANIEL B SOLAND
Sentiment: All, ACAD, CHIR, IDRA, KALV
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2021 | ACAD | ACADIA PHARMACEUTI ... | SOLAND DANIEL B | Director | Option Exercise | A | 0.00 | 6,391 | 0 | 6,391 | |
| Jun 24 2021 | ACAD | ACADIA PHARMACEUTI ... | SOLAND DANIEL B | Director | Option Exercise | A | 24.88 | 11,637 | 289,529 | 11,637 | |
| Mar 05 2021 | IDRA | IDERA PHARMACEUTIC ... | SOLAND DANIEL B | CHIEF OPERATING OFF ... | Buy | P | 3.90 | 10,000 | 38,950 | 28,843 | 18.8 K to 28.8 K (+53.07 %) |
| Jan 05 2021 | IDRA | IDERA PHARMACEUTIC ... | SOLAND DANIEL B | Chief Operating Off ... | Option Exercise | A | 4.02 | 200,000 | 804,000 | 200,000 | |
| Jan 05 2021 | IDRA | IDERA PHARMACEUTIC ... | SOLAND DANIEL B | Chief Operating Off ... | Option Exercise | A | 4.02 | 200,000 | 804,000 | 200,000 | |
| Oct 02 2020 | KALV | KalVista Pharmaceu ... | SOLAND DANIEL B | Director | Option Exercise | A | 12.88 | 7,000 | 90,160 | 7,000 | |
| Oct 02 2020 | KALV | KalVista Pharmaceu ... | SOLAND DANIEL B | Director | Option Exercise | A | 12.88 | 7,000 | 90,160 | 7,000 |